Akari Therapeutics Plc(AKTX)内部人交易:高管与董事近期交易
过去 18 个月,共有 7 位内部人为 Akari Therapeutics Plc(AKTX)报告了 44 笔 Form 4 交易(最近一笔 2026-11-19)。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-11-19 | Farag Kameel D. | Interim CFO | 买入 | 1,284 | $12,994 |
| 2026-11-19 | Farag Kameel D. | Interim CFO | 买入 | 1,589 | $12,998 |
| 2026-10-16 | Patel Sandip I | 董事 | 买入 | 4,313 | $34,068 |
| 2026-10-16 | Bazemore Robert B | 董事 | 买入 | 13,100 | $103,477 |
| 2026-10-16 | Prudo-Chlebosz Raymond | 董事 | 买入 | 9,072 | $71,660 |
| 2026-10-16 | Patel Samir Rashmikant | 董事 | 买入 | 6,300 | $49,764 |
| 2026-10-16 | Patel Sandip I | 董事 | 买入 | 12,100 | $95,578 |
| 2026-10-16 | Gaslightwala Abizer | CEO | 买入 | 19,333 | $8 |
| 2026-10-16 | Huh Hoyoung | 董事 | 买入 | 6,160 | $48,658 |
| 2026-10-16 | Bazemore Robert B | 董事 | 买入 | 4,677 | $36,944 |
| 2026-10-16 | Prudo-Chlebosz Raymond | 董事 | 买入 | 3,240 | $25,593 |
| 2026-10-16 | Patel Samir Rashmikant | 董事 | 买入 | 2,236 | $17,662 |
| 2026-10-16 | Huh Hoyoung | 董事 | 买入 | 17,249 | $136,250 |
| 2026-10-16 | Gaslightwala Abizer | CEO | 买入 | 7,733 | $3 |
| 2026-10-16 | Bazemore Robert B | 董事 | 买入 | 773 | $0 |
| 2026-10-16 | Patel Sandip I | 董事 | 买入 | 3,866 | $2 |
| 2026-10-16 | Bazemore Robert B | 董事 | 买入 | 3,093 | $1 |
| 2026-10-16 | Patel Sandip I | 董事 | 买入 | 6,186 | $2 |
| 2026-10-01 | Gaslightwala Abizer | CEO | 买入 | 6,430 | $62,500 |
| 2026-08-19 | Farag Kameel D. | Interim CFO | 买入 | 1,728 | $12,995 |
| 2026-08-05 | Farag Kameel D. | Interim CFO | 买入 | 1,130 | $12,995 |
| 2026-07-17 | Patel Samir Rashmikant | 董事 | 买入 | 1,209 | $9,672 |
| 2026-07-17 | Patel Samir Rashmikant | 董事 | 买入 | 15,466 | $0 |
| 2026-07-17 | Patel Samir Rashmikant | 董事 | 买入 | 5,799 | $0 |
| 2026-06-25 | Farag Kameel D. | Interim CFO | 买入 | 1,248 | $12,505 |
来源:SEC Form 4 申报文件 · 截至 2026-11-19